TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28003211

Group type: EXPERIMENTAL
Intervention: Hot-water immersion (30-min waist-level immersion in 42.1 ± 0.6°C water)
Number of subjects: 21
Study: 26069291

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (4 mg iv/4 weeks, 12 doses)
Number of subjects: 100
Study: 23441762

Group type: EXPERIMENTAL
Intervention: Levocetirizine 5 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Levocetirizine 10 mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Desloratadine 5 mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Desloratadine 10 mg
Number of subjects: 80
Study: 21941011

Group type: EXPERIMENTAL
Intervention: Cooling (wet bags of ice during each inter-set rest interval)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (no ice application)
Number of subjects: 16
Study: 19705620

Group type: EXPERIMENTAL
Intervention: Rapid test detecting heterophil antibodies
Number of subjects: 163

Group type: COMPARATOR
Intervention: Specific immunoglobulins directed against Epstein‐Barr virus (EBV)
Number of subjects: 163
Study: 16735654

Group type: EXPERIMENTAL
Intervention: Self-Administration of Medication (SAM) tool
Number of subjects: 56
Study: 15558387

Group type: EXPERIMENTAL
Intervention: Alpha liner with distal locking pin
Number of subjects: 13

Group type: COMPARATOR
Intervention: Pe‐Lite liner with neoprene suspension sleeve
Number of subjects: 13
Study: 11510389

Group type: EXPERIMENTAL
Intervention: Empirical treatment based on symptoms
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Cisapride
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Prompt endoscopy
Number of subjects: 349
Study: 9265939

Group type: EXPERIMENTAL
Intervention: Halothane
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control situation (baseline)
Number of subjects: 33
Study: 8333260

Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate 1%
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydroxypropyl methylcellulose 2%
Number of subjects: 0
Study: 3088858

Group type: EXPERIMENTAL
Intervention: Rioprostil 300 micrograms b.i.d.
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Rioprostil 600 micrograms hs
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 29082629

Group type: EXPERIMENTAL
Intervention: Rehospitalization within 30 days
Number of subjects: 6584

Group type: EXPERIMENTAL
Intervention: Early readmission (0-7 days)
Number of subjects: 6584

Group type: EXPERIMENTAL
Intervention: Late readmission (8-30 days)
Number of subjects: 6584
Study: 28434760

Group type: EXPERIMENTAL
Intervention: n‐3 polyunsaturated fatty acids (PUFA) supplementation at a dosage of 1.28 g/day for 12 weeks
Number of subjects: 88

Group type: COMPARATOR
Intervention: Soybean oil (control group) for 12 weeks
Number of subjects: 88
Study: 25194450

Group type: EXPERIMENTAL
Intervention: Moderate to vigorous intensity resistance training
Number of subjects: 51

Group type: COMPARATOR
Intervention: Stretching (placebo control)
Number of subjects: 51
Study: 24217302

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no levosimendan)
Number of subjects: 20
Study: 21402120

Group type: EXPERIMENTAL
Intervention: Mirtazapine (open label) for 6 weeks after initial treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mirtazapine (12 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (initial treatment)
Number of subjects: 0
Study: 18192497

Group type: EXPERIMENTAL
Intervention: Caregiver intervention (not specified in detail)
Number of subjects: 182
Study: 23120348

Group type: EXPERIMENTAL
Intervention: CT‐RT arm (neo‐adjuvant chemotherapy with Inj. Cisplatin 100 mg/m(2) on D(1) and Inj 5F.U. 700 mg/m(2) on D(1)‐D(4) at an interval of 21 days, followed by external radiation)
Number of subjects: 180

Group type: COMPARATOR
Intervention: RT arm (external radiotherapy only)
Number of subjects: 180
Study: 12210641

Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Medication management
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (CBT)
Number of subjects: 62
Study: 9604408

Group type: EXPERIMENTAL
Intervention: Standardized psychiatric assessment by a practice nurse and feedback to the GP (Study 1)
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Standardized psychiatric assessment by a practice nurse, feedback to the GP, and nurse-assisted follow-up care (Study 2)
Number of subjects: 577

Group type: COMPARATOR
Intervention: Nurse intervention groups (combined from Study 1 and Study 2)
Number of subjects: 577
Study: 7781842

Group type: EXPERIMENTAL
Intervention: Patients with macular oedema
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 2355104

Group type: EXPERIMENTAL
Intervention: Penbutolol 40 mg once daily (increased to 80 mg for poor responders)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 343414

Group type: EXPERIMENTAL
Intervention: mepindolol-sulfate
Number of subjects: 7

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 7
Study: 29264969

Group type: EXPERIMENTAL
Intervention: Fermented soymilk (FSM) with Lactobacillus casei Shirota
Number of subjects: 60

Group type: COMPARATOR
Intervention: Soymilk (SM) without isoflavones or probiotics
Number of subjects: 60
Study: 26265197

Group type: EXPERIMENTAL
Intervention: Topical diclofenac epolamine 1.3% patch
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Oral diclofenac 50 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Aspirin 325 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Diclofenac potassium 50 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Diclofenac potassium plus ASA 325 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Diclofenac patch plus aspirin
Number of subjects: 12
Study: 24879050

Group type: EXPERIMENTAL
Intervention: Larger provider groups
Number of subjects: 3100000

Group type: COMPARATOR
Intervention: Smaller provider groups
Number of subjects: 3100000
Study: 22366843

Group type: EXPERIMENTAL
Intervention: US-guided popliteal sciatic block (US-SPB) with 20 mL mepivacaine 1.5%
Number of subjects: 52

Group type: COMPARATOR
Intervention: Nerve stimulator-guided popliteal sciatic block (NS-SPB) with 20 mL mepivacaine 1.5%
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: US-guided popliteal sciatic block (US-SPB)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Nerve stimulator-guided popliteal sciatic block (NS-SPB)
Number of subjects: 52
Study: 20060945

Group type: EXPERIMENTAL
Intervention: IC41 vaccine via subcutaneous (s.c.) or intradermal (i.d.) injections weekly (16 injections) or every other week (8 injections)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: IC41 vaccine with imiquimod
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: IC41 vaccine via intradermal injections
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: IC41 vaccine
Number of subjects: 54
Study: 17358100

Group type: EXPERIMENTAL
Intervention: Insulin detemir
Number of subjects: 900

Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 900
Study: 15730512

Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ)
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Amodiaquine (AQ)
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Sulphadoxine-pyrimethamine (SP)
Number of subjects: 351
Study: 12049534

Group type: EXPERIMENTAL
Intervention: Nissen fundoplication with posterior cruroplasty
Number of subjects: 72

Group type: COMPARATOR
Intervention: Nissen fundoplication with posterior cruroplasty and onlay of polytetrafluoroethylene (PTFE) mesh
Number of subjects: 72
Study: 10357691

Group type: EXPERIMENTAL
Intervention: Tunneled femoral catheter
Number of subjects: 345

Group type: COMPARATOR
Intervention: Nontunneled femoral catheter (Control)
Number of subjects: 345
Study: 7607970

Group type: EXPERIMENTAL
Intervention: Radiation therapy (RT) plus steroids
Number of subjects: 275

Group type: COMPARATOR
Intervention: Radiation therapy (RT) alone
Number of subjects: 275
Study: 1977179

Group type: EXPERIMENTAL
Intervention: Triazolam (2.25-9.0 micrograms/kg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Lorazepam (7.5-45 micrograms/kg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 623119

Group type: EXPERIMENTAL
Intervention: Aluminum hydroxide (6 g daily, three times a day)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Aluminum hydroxide capsules
Number of subjects: 8
Study: 30905872

Group type: EXPERIMENTAL
Intervention: Smartphone app
Number of subjects: 80

Group type: COMPARATOR
Intervention: Logbook
Number of subjects: 80
Study: 28445286

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (Group R)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 90
Study: 25318368

Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy (LA)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Open appendectomy (OA)
Number of subjects: 114
Study: 24352716

Group type: EXPERIMENTAL
Intervention: Bupropion (≤300 mg/day)
Number of subjects: 999

Group type: COMPARATOR
Intervention: SSRIs (sertraline, paroxetine, or escitalopram)
Number of subjects: 999
Study: 23021641

Group type: EXPERIMENTAL
Intervention: Vertebroplasty for fracture age of 12 weeks or less
Number of subjects: 256

Group type: COMPARATOR
Intervention: Vertebroplasty for fracture age greater than 12 weeks
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Vertebroplasty for fracture age of 6 weeks or less
Number of subjects: 256

Group type: COMPARATOR
Intervention: Vertebroplasty for fracture age greater than 6 weeks
Number of subjects: 256
Study: 18927130

Group type: EXPERIMENTAL
Intervention: 5% O(2) environment
Number of subjects: 230

Group type: COMPARATOR
Intervention: 21% O(2) (atmospheric) environment
Number of subjects: 230
Study: 17397743

Group type: EXPERIMENTAL
Intervention: Valdecoxib (Bextra), administered systemically
Number of subjects: 10
Study: 15200450

Group type: EXPERIMENTAL
Intervention: pH neutral, lactate‐buffered, low GDP fluid (balance)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Conventional, acidic, lactate‐buffered fluid (SPDF)
Number of subjects: 86
Study: 12074777

Group type: EXPERIMENTAL
Intervention: Combination of 6g of L-arginine glutamate and 6 mg of yohimbine hydrochloride (AY)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 6 mg of yohimbine hydrochloride (YP)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (PP)
Number of subjects: 45
Study: 9718596

Group type: EXPERIMENTAL
Intervention: Tryptophan depletion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Balanced amino acid mixtures
Number of subjects: 0
Study: 1986031

Group type: EXPERIMENTAL
Intervention: Scopolamine 3.0 micrograms/kg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Scopolamine 6.0 micrograms/kg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Scopolamine 3.0 micrograms/kg and 6.0 micrograms/kg
Number of subjects: 8
Study: 6342395

Group type: EXPERIMENTAL
Intervention: Maternal magnesium sulfate infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 0
Study: 31784875

Group type: COMPARATOR
Intervention: Dimethyl fumarate (Tecfidera®), administered twice daily.
Number of subjects: 0
Study: 30193081

Group type: EXPERIMENTAL
Intervention: Pancreatic enzyme replacement therapy (PERT) at maximum intake of 75,000 units per meal
Number of subjects: 10

Group type: COMPARATOR
Intervention: No PERT treatment
Number of subjects: 10
Study: 26520703

Group type: EXPERIMENTAL
Intervention: Intermittent androgen deprivation (IAD) with leuprorelin acetate (Eligard) 22.5mg 3‐mo depot for 36 months
Number of subjects: 933

Group type: COMPARATOR
Intervention: Continuous androgen deprivation (CAD) with leuprorelin acetate (Eligard) 22.5mg 3‐mo depot for 36 months
Number of subjects: 933
Study: 25204479

Group type: EXPERIMENTAL
Intervention: Prednisolone alone (P; N = 23)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Prednisolone and azathioprine (P/A; N = 23)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Prednisolone and mycophenolate mofetil (P/M; N = 21)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Prednisolone and cyclophosphamide (P/C; N = 20)
Number of subjects: 87
Study: 22500015

Group type: EXPERIMENTAL
Intervention: Incredible Years Teacher Training intervention
Number of subjects: 225

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 225
Study: 19779382

Group type: EXPERIMENTAL
Intervention: BZA 20 mg/CE 0.625 mg
Number of subjects: 664

Group type: EXPERIMENTAL
Intervention: BZA 20 mg/CE 0.45 mg
Number of subjects: 664

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 664
Study: 18799988

Group type: EXPERIMENTAL
Intervention: Hypocaloric diet with treadmill walking (low- or high-intensity)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Hypocaloric diet without treadmill walking
Number of subjects: 34

Group type: COMPARATOR
Intervention: Weight regain
Number of subjects: 34
Study: 16001926

Group type: EXPERIMENTAL
Intervention: Bottle-feeding
Number of subjects: 45

Group type: COMPARATOR
Intervention: Spoon-feeding
Number of subjects: 45
Study: 14517784

Group type: EXPERIMENTAL
Intervention: Hiatus Hernia (HH) patients
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Non-Hernia (NHH) patients
Number of subjects: 23

Group type: COMPARATOR
Intervention: Normal subjects (NL)
Number of subjects: 23
Study: 10809945

Group type: EXPERIMENTAL
Intervention: Tibolon (replacement therapy)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 54

Group type: COMPARATOR
Intervention: Before treatment
Number of subjects: 54
Study: 9345074

Group type: EXPERIMENTAL
Intervention: 9 weeks of induction chemotherapy (vincristine, doxorubicin, cyclophosphamide, prednisone) followed by 24 weeks of continuation chemotherapy (mercaptopurine, methotrexate) without radiotherapy
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: 24 weeks of continuation chemotherapy after 9 weeks of induction chemotherapy
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: 24 weeks of continuation chemotherapy with radiotherapy after 9 weeks of induction chemotherapy
Number of subjects: 340

Group type: COMPARATOR
Intervention: No further therapy after 9 weeks of induction chemotherapy
Number of subjects: 340
Study: 8403122

Group type: EXPERIMENTAL
Intervention: Modified retrobulbar block (MRB)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Classical retrobulbar block (RB)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Peribulbar block (PB)
Number of subjects: 150
Study: 2867316

Group type: EXPERIMENTAL
Intervention: 10 min Apgar score less than or equal to 5
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Presence of moderate or severe encephalopathy
Number of subjects: 122
Study: 29990565

Group type: EXPERIMENTAL
Intervention: Vildagliptin (METV)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Glibenclamide (METG)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control (exercise session)
Number of subjects: 13
Study: 27484339

Group type: EXPERIMENTAL
Intervention: Remifentanil infusion (0.1 μg/kg/min)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Remifentanil infusion (0.1 μg/kg/min) + Alfentanil (5 μg/kg 10 min before end of surgery)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Sevoflurane alone
Number of subjects: 102
Study: 24762066

Group type: EXPERIMENTAL
Intervention: Anthracycline-based chemotherapy followed by taxane therapy (Arm A)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Taxane therapy followed by anthracycline-based chemotherapy (Arm B)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Docetaxel chemotherapy
Number of subjects: 119

Group type: COMPARATOR
Intervention: Chemotherapy sequence (Arm A vs Arm B)
Number of subjects: 119
Study: 23174472

Group type: EXPERIMENTAL
Intervention: Travel by walking (TBW) before and after school
Number of subjects: 3076

Group type: EXPERIMENTAL
Intervention: Consistent walkers (TBW in both sixth and eighth grades)
Number of subjects: 3076
Study: 20205108

Group type: EXPERIMENTAL
Intervention: sulfonylurea
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: sulfonylurea plus insulin
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: routine diet and sulfonylurea therapy
Number of subjects: 28

Group type: COMPARATOR
Intervention: baseline
Number of subjects: 28
Study: 18580739

Group type: EXPERIMENTAL
Intervention: Back school program plus medication (n = 50)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Medication only (n = 52)
Number of subjects: 102
Study: 16014852

Group type: EXPERIMENTAL
Intervention: Sulfadoxine-pyrimethamine (SP) and iron with folic acid supplementation
Number of subjects: 303

Group type: COMPARATOR
Intervention: Sulfadoxine-pyrimethamine (SP) and iron without folic acid supplementation
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Folic acid supplementation
Number of subjects: 303
Study: 12185327

Group type: EXPERIMENTAL
Intervention: Tamoxifen for 5 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ovarian ablation or suppression combined with tamoxifen
Number of subjects: 0
Study: 10072410

Group type: EXPERIMENTAL
Intervention: Clozapine (6.25 to 50 mg per day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 60
Study: 7793648

Group type: EXPERIMENTAL
Intervention: 0.2 mg oral clonidine
Number of subjects: 8

Group type: COMPARATOR
Intervention: 50 mg lidocaine
Number of subjects: 8
Study: 1684743

Group type: EXPERIMENTAL
Intervention: Sulindac
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Diclofenac
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 7041287

Group type: EXPERIMENTAL
Intervention: Terbutaline sulphate aerosol
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo aerosol
Number of subjects: 26
Study: 30631933

Group type: EXPERIMENTAL
Intervention: Laparoscopic removal of vagal nerve blocking device
Number of subjects: 30
Study: 28113631

Group type: EXPERIMENTAL
Intervention: Human footstep sounds
Number of subjects: 0

Group type: COMPARATOR
Intervention: Computer-generated sound
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Asynchronous auditory feedback
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Synchronous auditory feedback
Number of subjects: 0
Study: 27578062

Group type: EXPERIMENTAL
Intervention: Focused history in series choreography (after primary survey)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Focused history in parallel choreography (concurrent with primary survey)
Number of subjects: 14
Study: 23371750

Group type: EXPERIMENTAL
Intervention: Right anodal/left cathodal stimulation
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Left anodal/right cathodal stimulation
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 32
Study: 20063407

Group type: EXPERIMENTAL
Intervention: LiquiPrep® (LP)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Papanicolaou (Pap) smear
Number of subjects: 194
Study: 20009130

Group type: EXPERIMENTAL
Intervention: Interferon-ribavirin treatment
Number of subjects: 44
Study: 17972478

Group type: EXPERIMENTAL
Intervention: Memory-encoding task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Search tasks (defined by category or exemplar)
Number of subjects: 0
Study: 15058117

Group type: EXPERIMENTAL
Intervention: Propofol 2 mg/kg with rocuronium 0.6 mg/kg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Thiopentone 4 mg/kg with rocuronium 0.6 mg/kg
Number of subjects: 40
Study: 11302283

Group type: EXPERIMENTAL
Intervention: Low dose diuretic (indapamide sustained release 1.5mg daily) and additional ACE inhibitor (perindopril) therapy if required
Number of subjects: 2100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2100
Study: 9868810

Group type: EXPERIMENTAL
Intervention: Hypnosis with forced recall
Number of subjects: 300

Group type: COMPARATOR
Intervention: Waking condition
Number of subjects: 300

Group type: COMPARATOR
Intervention: Non-forced recall
Number of subjects: 300
Study: 7979670

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (150 mg/day) for 7 days before operation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no coenzyme Q10)
Number of subjects: 40
Study: 2659340

Group type: EXPERIMENTAL
Intervention: Tetracaine in 8% glucose
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Tetracaine in 5% glucose
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Bupivacaine in 8% glucose
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Bupivacaine in 5% glucose
Number of subjects: 80
Study: 29875020

Group type: EXPERIMENTAL
Intervention: 5 micrograms dexmedetomidine (BD group)
Number of subjects: 90

Group type: COMPARATOR
Intervention: 25 micrograms fentanyl (BF group)
Number of subjects: 90

Group type: COMPARATOR
Intervention: 0.5 ml normal saline (BN group)
Number of subjects: 90
Study: 28319270

Group type: EXPERIMENTAL
Intervention: PFD patch
Number of subjects: 30

Group type: COMPARATOR
Intervention: Laser alone
Number of subjects: 30
Study: 26044495

Group type: EXPERIMENTAL
Intervention: Intervention group (multi-component antenatal vaccine promotion package)
Number of subjects: 325

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 325
Study: 23473784

Group type: EXPERIMENTAL
Intervention: Chronic pain patients receiving opioids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chronic pain patients off opioid treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chronic pain patients (generalized and neuropathic pain)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chronic pain patients (localized pain)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chronic pain patients (overall)
Number of subjects: 0
Study: 20374275

Group type: EXPERIMENTAL
Intervention: Liposomal amphotericin B (L-AMB) 3 mg/kg QD for 14 days followed by L-AMB 3 mg/kg QD
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Liposomal amphotericin B (L-AMB) 10 mg/kg QD for 14 days followed by L-AMB 3 mg/kg QD
Number of subjects: 91
Study: 18245686

Group type: EXPERIMENTAL
Intervention: 0.12 percent chlorhexidine lavage during ultrasonic scaling and use of chlorhexidine mouthrinse at home
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 140